Search results
1 lut 2024 · KDIGO guidelines regarding CKD-MBD, the treatment is targeted at lowering high serum phosphate and maintaining serum calcium in the age-appropriate normal range in children with CKD G3a–G5D. In this group of children, it is reasonable to base the choice of phosphate-lowering treatment on serum calcium levels, although this statement evidence ...
- Clinical practice recommendations for treatment with active vitamin D ...
In advanced CKD, active vitamin D analogues, including...
- Vitamin D insufficiency and hyperparathyroidism in children with ...
A retrospective review of patients followed in the chronic...
- Clinical practice recommendations for treatment with active vitamin D ...
15 kwi 2021 · In this review we revisit normal calcium physiology and define hypo- and hypercalcemia in children. We also provide a physiology-based approach for diagnosis of pediatric calcium disorders with treatment recommendations.
26 maj 2017 · We present clinical practice recommendations for the use of ergocalciferol (vitamin D 2) and cholecalciferol (vitamin D 3) in children with CKD Stages 2–5 and on dialysis. A parallel document addresses treatment recommendations for active vitamin D analogue therapy.
The management of symptomatic hypercalcemia includes interventions such as fluids, antiresorptive medications, and parathyroid surgery. This article presents a clinical, biochemical, and genetic approach to investigating the causes of pediatric hypercalcemia. © 2017 The Authors.
30 paź 2019 · In children with chronic kidney disease (CKD), optimal control of bone and mineral homeostasis is essential, not only for the prevention of debilitating skeletal complications and achieving adequate growth but also for preventing vascular calcification and cardiovascular disease.
1 lip 2017 · In advanced CKD, active vitamin D analogues, including alfacalcidol, calcitriol and paricalcitol, are routinely administered. There are few studies on the use of vitamin D analogues in children with CKD and on dialysis. It is difficult to define bone-specific outcomes that can guide treatment with active vitamin D analogues in children with CKD ...
A retrospective review of patients followed in the chronic renal insufficiency clinic at Children's Hospital of Michigan assessed the prevalence of vitamin D deficiency in CKD stages 2-4 and evaluated the effect of treatment with ergocalciferol on serum parathormone (PTH).
